No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
Lake Street Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Raises Target Price to $6
KORU Medical Systems' Shares Fall After Downgrade From Piper Sandler
This Informatica Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Piper Sandler Downgrades KORU Medical Systems to Neutral, Maintains Price Target to $4.5
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System